加载中
NASDAQHealthcareMedical - Diagnostics & Research
最新数据
US$140.58
+US$7.97 · +6.01%
GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients with clinical suspicion of cancer. The company also provides development services, including support for ongoing clinical studies, pilot testing, research, and therapy development. In addition, its precision oncology portfolio consists of n RUO-targeted methylation-based platform that enables applications for disease prognostication, risk stratification, minimal residual disease detection, and recurrence and relapse monitoring. The company was incorporated in 2015 and is headquartered in Menlo Park, California.
前收盘价
US$140.58
+US$7.97 · +6.01%
盘中时间采用ET。市场数据可能有所延迟。
GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients with clinical suspicion of cancer. The company also provides development services, including support for ongoing clinical studies, pilot testing, research, and therapy development. In addition, its precision oncology portfolio consists of n RUO-targeted methylation-based platform that enables applications for disease prognostication, risk stratification, minimal residual disease detection, and recurrence and relapse monitoring. The company was incorporated in 2015 and is headquartered in Menlo Park, California.
日内区间
当前US$140.58
52周区间
当前US$140.58
盘中时间采用ET。市场数据可能有所延迟。
GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients with clinical suspicion of cancer. The company also provides development services, including support for ongoing clinical studies, pilot testing, research, and therapy development. In addition, its precision oncology portfolio consists of n RUO-targeted methylation-based platform that enables applications for disease prognostication, risk stratification, minimal residual disease detection, and recurrence and relapse monitoring. The company was incorporated in 2015 and is headquartered in Menlo Park, California.
日内区间
当前US$140.58
52周区间
当前US$140.58
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目（USD） | 2025财年 | 2024财年 | 2023财年 | 2022财年 | 2021财年 |
|---|---|---|---|---|---|
| 营收 | 1.47亿 USD | 1.26亿 USD | 9310.5万 USD | 5555万 USD | 1461.2万 USD |
| 销货成本 | 2.1亿 USD | 2.04亿 USD | 1.89亿 USD | 1.72亿 USD | 1.15亿 USD |
| 毛利 | −6257.3万 USD | −7802.2万 USD | −9561.1万 USD | −1.16亿 USD | −1亿 USD |
| 研究与开发 | 1.96亿 USD | 3.22亿 USD | 3.39亿 USD | 3.3亿 USD | 4.6亿 USD |
| 销售、一般及管理费用 | 2.76亿 USD | 3.68亿 USD | 3.63亿 USD | 2.96亿 USD | 2.34亿 USD |
| 营业费用 | 4.72亿 USD | 21.11亿 USD | 14.2亿 USD | 53.26亿 USD | 11.65亿 USD |
| 利息收入 | 2865.2万 USD | 2673.3万 USD | 795.4万 USD | 174万 USD | 33.2万 USD |
| 折旧和摊销 | 1.56亿 USD | 1.58亿 USD | 1.59亿 USD | 1.55亿 USD | 5844.9万 USD |
| 营业利润 | −5.34亿 USD | −21.89亿 USD | −15.15亿 USD | −54.43亿 USD | −12.65亿 USD |
| 净利润 | −4.08亿 USD | −20.27亿 USD | −14.66亿 USD | −53.99亿 USD | −12.48亿 USD |
公司数据更新于 2026年10月11日。
近期已公布业绩
近期已公布业绩
第三方分析师预期可能变化，并非 GoAI 建议。
平均目标
US$106.14
下跌空间 24.50%报告持有此股票敞口的交易所交易基金。
iShares Russell 2000 ETFIWM1.44亿0.18%787.4亿 USD0.19%US$278.94+0.49%
State Street SPDR S&P Biotech ETFXBI1.32亿1.33%98.74亿 USD0.35%US$153.77+3.00%
Vanguard Morningstar Total Stock Market ETFVTI9777.5万0.00%2.3万亿 USD0.03%US$381.94+0.63%
iShares Biotechnology ETFIBB4332.4万0.41%108.2亿 USD0.44%US$206.49+3.00%
Dimensional - US Small Cap ETFDFAS3710.41万0.11%338.69亿 USD0.31%US$78.35+0.32%
Schwab U.S. Small-Cap ETFSCHA3144.58万0.14%218.24亿 USD0.03%US$32.79+0.40%
Vanguard Extended Market ETFVXF3001.84万0.03%954亿 USD0.05%US$235+0.80%
Vanguard Russell 2000 ETFVTWO1884.7万0.10%180亿 USD0.06%US$112.66+0.50%iShares Russell 2000 ETFIWMState Street SPDR S&P Biotech ETFXBIVanguard Morningstar Total Stock Market ETFVTIiShares Biotechnology ETFIBBDimensional - US Small Cap ETFDFASSchwab U.S. Small-Cap ETFSCHAVanguard Extended Market ETFVXFVanguard Russell 2000 ETFVTWOAI 生成内容及延迟市场数据仅供信息与教育用途，不构成投资建议。
